Medicamen Biotech Ltd.
•₹ 244.550.33%
2026-08-21
PROS
- Latest quarter profit grew 54.1% YoY, showing strong momentum
- Company has a consistent dividend-paying track record
- Company maintains a comfortable, low leverage position
CONS
- Operating cash flow has been negative in recent years
- A large part of profit comes from other income (48.8% of PBT)
- Receivables are growing faster than sales - a possible quality concern
- Company has a low return on equity of 6.9% over last 3 years
- Company has a low return on capital employed of 9.3%
- Poor cash conversion - profits are not backed by operating cash flow (CFO/PAT -0.17x)
* The pros and cons are machine generated based on quantitative rules.
Peer comparison
EDIT COLUMNS| S.No. | Name | CMP Rs. | P/E | Mar Cap Rs.Cr. | Div Yld % | NP Qtr Rs.Cr. | Qtr Profit Var % | Sales Qtr Rs.Cr. | Qtr Sales Var % | ROCE % | OPM % |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. | SUNPHARMA | 1901.00 | 37.71 | 456113.58 | 0.84 | 2901.23 | 26.53 | 15299.88 | 10.98 | 19.11 | 28.81 |
| 2. | DIVISLAB | 8587.00 | 77.93 | 227957.87 | 0.35 | 902.00 | 65.50 | 3080.00 | 27.80 | 21.51 | 40.75 |
| 3. | TORNTPHARM | 4994.90 | 87.11 | 189989.94 | 0.76 | 566.00 | 3.28 | 4921.00 | 57.32 | 19.27 | 33.81 |
| 4. | CIPLA | 1437.65 | 34.46 | 116141.01 | 0.90 | 785.55 | -39.18 | 7119.28 | 4.13 | 16.00 | 16.73 |
| 5. | ZYDUSLIFE | 1108.80 | 24.51 | 110603.22 | 0.09 | 990.20 | -34.90 | 8017.00 | 23.97 | 21.39 | 24.54 |
| 6. | LUPIN | 2203.10 | 18.22 | 100733.42 | 0.82 | 1416.98 | 16.01 | 8276.89 | 34.28 | 28.86 | 29.59 |
| 7. | DRREDDY | 1181.35 | 30.60 | 98604.43 | 0.68 | 435.60 | -69.10 | 8099.80 | -5.21 | 13.75 | 10.63 |
| 8. | MANKIND | 2385.00 | 48.22 | 98499.54 | 0.04 | 574.09 | 29.12 | 4030.59 | 12.89 | 13.24 | 26.30 |
| 9. | LAURUSLABS | 1823.00 | 90.09 | 98498.92 | 0.11 | 3620.70 | 2139.42 | 20263.10 | 1191.00 | 18.20 | 31.50 |
| 10. | AUROPHARMA | 1606.40 | 24.90 | 92428.71 | 0.25 | 1032.03 | 25.22 | 9150.35 | 17.44 | 12.76 | 20.54 |
| 11. | BIOCON | 412.10 | 135.59 | 67159.70 | 0.12 | 136.80 | 53.36 | 4336.00 | 10.89 | 3.26 | 19.54 |
| 12. | MEDICAMEQ | 244.70 | 30.65 | 331.88 | 0.41 | 1.85 | 15.30 | 47.90 | 11.26 | 5.77 | 9.03 |
Detailed Comparison with:
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 40 | 43 | 44 | 45 | 41 | 43 | 41 | 26 | 38 | 42 | 43 | 55 | 44 | |
| 33 | 37 | 39 | 38 | 37 | 36 | 35 | 27 | 34 | 37 | 38 | 51 | 41 | |
| Operating Profit | — | — | — | — | — | — | — | — | — | — | — | — | — |
| OPM % | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Other Income | 0 | 1 | 1 | 1 | 1 | 0 | 0 | 5 | 0 | 0 | 1 | 2 | 1 |
| Interest | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Depreciation | 2 | 2 | 2 | 2 | 2 | 3 | 2 | 0 | 2 | 2 | 2 | 2 | 2 |
| 5 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 2 | 3 | 3 | 4 | 3 | |
| Tax % | 14.37% | 24.75% | 30.92% | 16.62% | 25.17% | 30.37% | 27.59% | 20.72% | 24.42% | 20.22% | 15.91% | 15.86% | 22.44% |
| Net Profit | 4 | 3 | 3 | 3 | 2 | 2 | 3 | 2 | 2 | 2 | 3 | 3 | 3 |
| 3 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 2 | 2 | 2 | 0 | |
| Equity Capital | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 14 | 14 | 14 | 14 | 14 |
| Reserves | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Promoter Pledge % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Equity Capital | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 14 | 14 | 14 | 14 | 14 |
| Reserves | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Promoter Pledge % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Jun 2023
- 40
- 33
- Operating Profit
- —
- OPM %
- —
- Other Income
- 0
- Interest
- 1
- Depreciation
- 2
- 5
- Tax %
- 14.37%
- Net Profit
- 4
- 3
- Equity Capital
- 13
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 13
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Sep 2023
- 43
- 37
- Operating Profit
- —
- OPM %
- —
- Other Income
- 1
- Interest
- 1
- Depreciation
- 2
- 4
- Tax %
- 24.75%
- Net Profit
- 3
- 2
- Equity Capital
- 13
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 13
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Dec 2023
- 44
- 39
- Operating Profit
- —
- OPM %
- —
- Other Income
- 1
- Interest
- 1
- Depreciation
- 2
- 4
- Tax %
- 30.92%
- Net Profit
- 3
- 2
- Equity Capital
- 13
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 13
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Mar 2024
- 45
- 38
- Operating Profit
- —
- OPM %
- —
- Other Income
- 1
- Interest
- 2
- Depreciation
- 2
- 4
- Tax %
- 16.62%
- Net Profit
- 3
- 2
- Equity Capital
- 13
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 13
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Jun 2024
- 41
- 37
- Operating Profit
- —
- OPM %
- —
- Other Income
- 1
- Interest
- 1
- Depreciation
- 2
- 3
- Tax %
- 25.17%
- Net Profit
- 2
- 2
- Equity Capital
- 13
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 13
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Sep 2024
- 43
- 36
- Operating Profit
- —
- OPM %
- —
- Other Income
- 0
- Interest
- 1
- Depreciation
- 3
- 3
- Tax %
- 30.37%
- Net Profit
- 2
- 2
- Equity Capital
- 13
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 13
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Dec 2024
- 41
- 35
- Operating Profit
- —
- OPM %
- —
- Other Income
- 0
- Interest
- 1
- Depreciation
- 2
- 3
- Tax %
- 27.59%
- Net Profit
- 3
- 2
- Equity Capital
- 13
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 13
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Mar 2025
- 26
- 27
- Operating Profit
- —
- OPM %
- —
- Other Income
- 5
- Interest
- 1
- Depreciation
- 0
- 3
- Tax %
- 20.72%
- Net Profit
- 2
- 2
- Equity Capital
- 13
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 13
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Jun 2025
- 38
- 34
- Operating Profit
- —
- OPM %
- —
- Other Income
- 0
- Interest
- 1
- Depreciation
- 2
- 2
- Tax %
- 24.42%
- Net Profit
- 2
- 1
- Equity Capital
- 14
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 14
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Sep 2025
- 42
- 37
- Operating Profit
- —
- OPM %
- —
- Other Income
- 0
- Interest
- 1
- Depreciation
- 2
- 3
- Tax %
- 20.22%
- Net Profit
- 2
- 2
- Equity Capital
- 14
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 14
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Dec 2025
- 43
- 38
- Operating Profit
- —
- OPM %
- —
- Other Income
- 1
- Interest
- 1
- Depreciation
- 2
- 3
- Tax %
- 15.91%
- Net Profit
- 3
- 2
- Equity Capital
- 14
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 14
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Mar 2026
- 55
- 51
- Operating Profit
- —
- OPM %
- —
- Other Income
- 2
- Interest
- 1
- Depreciation
- 2
- 4
- Tax %
- 15.86%
- Net Profit
- 3
- 2
- Equity Capital
- 14
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 14
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Jun 2026
- 44
- 41
- Operating Profit
- —
- OPM %
- —
- Other Income
- 1
- Interest
- 1
- Depreciation
- 2
- 3
- Tax %
- 22.44%
- Net Profit
- 3
- 0
- Equity Capital
- 14
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 14
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 67 | 82 | 112 | 123 | 117 | 110 | 115 | 138 | 172 | 151 | 184 | |
| 62 | 71 | 95 | 105 | 99 | 90 | 91 | 113 | 145 | 134 | 168 | |
| Operating Profit | 6 | 12 | 19 | 21 | 20 | 21 | 26 | 27 | 30 | 23 | — |
| OPM % | 9 | 14 | 17 | 17 | 17 | 19 | 22 | 20 | 17 | 15 | — |
| Other Income | 1 | 0 | 2 | 4 | 2 | 1 | 2 | 2 | 2 | 6 | 4 |
| Interest | 4 | 4 | 3 | 1 | 1 | 2 | 2 | 3 | 6 | 4 | 3 |
| Depreciation | 2 | 2 | 2 | 2 | 2 | 3 | 6 | 6 | 7 | 7 | 7 |
| 1 | 6 | 14 | 18 | 17 | 17 | 18 | 17 | 17 | 13 | 13 | |
| Tax % | 32 | 19 | 27 | 31 | 26 | 25 | 18 | 13 | 21 | 26 | 19 |
| Net Profit | 0 | 5 | 10 | 12 | 12 | 12 | 15 | 15 | 13 | 9 | 10 |
| EPS | 0 | 0 | 0 | 0 | 0 | 10 | 12 | 12 | 10 | 7 | — |
| Dividend Payout % | 0 | 0 | 12 | 10 | 5 | 10 | 8 | 8 | 10 | 13 | — |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share of Associates | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Adjusted EPS | 0 | 5 | 9 | 10 | 10 | 10 | 12 | 12 | 10 | 7 | — |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share of Associates | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Adjusted EPS | 0 | 5 | 9 | 10 | 10 | 10 | 12 | 12 | 10 | 7 | — |
Mar 2016
- 67
- 62
- Operating Profit
- 6
- OPM %
- 9
- Other Income
- 1
- Interest
- 4
- Depreciation
- 2
- 1
- Tax %
- 32
- Net Profit
- 0
- EPS
- 0
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 0
Mar 2017
- 82
- 71
- Operating Profit
- 12
- OPM %
- 14
- Other Income
- 0
- Interest
- 4
- Depreciation
- 2
- 6
- Tax %
- 19
- Net Profit
- 5
- EPS
- 0
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 5
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 5
Mar 2018
- 112
- 95
- Operating Profit
- 19
- OPM %
- 17
- Other Income
- 2
- Interest
- 3
- Depreciation
- 2
- 14
- Tax %
- 27
- Net Profit
- 10
- EPS
- 0
- Dividend Payout %
- 12
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 9
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 9
Mar 2019
- 123
- 105
- Operating Profit
- 21
- OPM %
- 17
- Other Income
- 4
- Interest
- 1
- Depreciation
- 2
- 18
- Tax %
- 31
- Net Profit
- 12
- EPS
- 0
- Dividend Payout %
- 10
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 10
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 10
Mar 2020
- 117
- 99
- Operating Profit
- 20
- OPM %
- 17
- Other Income
- 2
- Interest
- 1
- Depreciation
- 2
- 17
- Tax %
- 26
- Net Profit
- 12
- EPS
- 0
- Dividend Payout %
- 5
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 10
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 10
Mar 2021
- 110
- 90
- Operating Profit
- 21
- OPM %
- 19
- Other Income
- 1
- Interest
- 2
- Depreciation
- 3
- 17
- Tax %
- 25
- Net Profit
- 12
- EPS
- 10
- Dividend Payout %
- 10
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 10
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 10
Mar 2022
- 115
- 91
- Operating Profit
- 26
- OPM %
- 22
- Other Income
- 2
- Interest
- 2
- Depreciation
- 6
- 18
- Tax %
- 18
- Net Profit
- 15
- EPS
- 12
- Dividend Payout %
- 8
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 12
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 12
Mar 2023
- 138
- 113
- Operating Profit
- 27
- OPM %
- 20
- Other Income
- 2
- Interest
- 3
- Depreciation
- 6
- 17
- Tax %
- 13
- Net Profit
- 15
- EPS
- 12
- Dividend Payout %
- 8
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 12
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 12
Mar 2024
- 172
- 145
- Operating Profit
- 30
- OPM %
- 17
- Other Income
- 2
- Interest
- 6
- Depreciation
- 7
- 17
- Tax %
- 21
- Net Profit
- 13
- EPS
- 10
- Dividend Payout %
- 10
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 10
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 10
Mar 2025
- 151
- 134
- Operating Profit
- 23
- OPM %
- 15
- Other Income
- 6
- Interest
- 4
- Depreciation
- 7
- 13
- Tax %
- 26
- Net Profit
- 9
- EPS
- 7
- Dividend Payout %
- 13
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 7
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 7
TTM
- 184
- 168
- Operating Profit
- —
- OPM %
- —
- Other Income
- 4
- Interest
- 3
- Depreciation
- 7
- 13
- Tax %
- 19
- Net Profit
- 10
- EPS
- —
- Dividend Payout %
- —
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- —
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- —
COMPOUNDED SALES GROWTH
- 10 Years:
- 7%
- 5 Years:
- 5%
- 3 Years:
- 9%
COMPOUNDED PROFIT GROWTH
- 10 Years:
- 36%
- 5 Years:
- -5%
- 3 Years:
- -14%
STOCK PRICE CAGR
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- -31%
- 1 Year:
- -33%
RETURN ON EQUITY
- 10 Years:
- 12%
- 5 Years:
- 8%
- 3 Years:
- 7%
- Last Year:
- 5%
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| LIABILITIES | - | - | - | - | - | - | - | - | - | - |
| Equity Capital | 10 | 11 | 12 | 12 | 12 | 12 | 12 | 13 | 13 | 13 |
| 8 | 15 | 63 | 75 | 110 | 122 | 136 | 180 | 196 | 205 | |
| 15 | 14 | 14 | 12 | 8 | 12 | 21 | 25 | 29 | 26 | |
| Trade Payables | 19 | 22 | 22 | 31 | 32 | 30 | 42 | 46 | 38 | 41 |
| 9 | 11 | 7 | 8 | 14 | 16 | 15 | 12 | 16 | 5 | |
| Total Liabilities | 60 | 73 | 118 | 137 | 176 | 192 | 225 | 275 | 292 | 290 |
| ASSETS | - | - | - | - | - | - | - | - | - | - |
| 19 | 19 | 25 | 24 | 34 | 90 | 92 | 92 | 91 | 86 | |
| Capital Work in Progress | 0 | 0 | 0 | 15 | 40 | 0 | 0 | 0 | 0 | 0 |
| 0 | 0 | 0 | 0 | 2 | 2 | 2 | 4 | 8 | 8 | |
| 11 | 14 | 14 | 15 | 17 | 5 | 27 | 45 | 59 | 62 | |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 48 | 59 | |
| Cash & Bank | 3 | 3 | 23 | 9 | 2 | 3 | 4 | 20 | 15 | 4 |
| 27 | 37 | 55 | 74 | 81 | 92 | 100 | 113 | 71 | 72 | |
| Total Assets | 60 | 73 | 118 | 137 | 176 | 192 | 225 | 275 | 292 | 290 |
| Total Debt | 20 | 18 | 14 | 12 | 11 | 19 | 26 | 26 | 30 | 27 |
| Net Working Capital | 3 | 11 | 50 | 48 | 47 | 42 | 50 | 78 | 70 | 81 |
| Contingent Liabilities | 0 | 8 | 4 | 5 | 6 | 5 | 6 | 0 | 0 | 0 |
| Book Value per Share | 17.92 | 24.73 | 63.68 | 73.69 | 98.58 | 104.52 | 114.84 | 146.79 | 159.34 | 165.97 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Total Debt | 20 | 18 | 14 | 12 | 11 | 19 | 26 | 26 | 30 | 27 |
| Net Working Capital | 3 | 11 | 50 | 48 | 47 | 42 | 50 | 78 | 70 | 81 |
| Contingent Liabilities | 0 | 8 | 4 | 5 | 6 | 5 | 6 | 0 | 0 | 0 |
| Book Value per Share | 17.92 | 24.73 | 63.68 | 73.69 | 98.58 | 104.52 | 114.84 | 146.79 | 159.34 | 165.97 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
Mar 2016
- Equity Capital
- 10
- 8
- 15
- Trade Payables
- 19
- 9
- Total Liabilities
- 60
- 19
- Capital Work in Progress
- 0
- 0
- 11
- 0
- Cash & Bank
- 3
- 27
- Total Assets
- 60
- Total Debt
- 20
- Net Working Capital
- 3
- Contingent Liabilities
- 0
- Book Value per Share
- 17.92
- Face Value
- 10.00
- Total Debt
- 20
- Net Working Capital
- 3
- Contingent Liabilities
- 0
- Book Value per Share
- 17.92
- Face Value
- 10.00
Mar 2017
- Equity Capital
- 11
- 15
- 14
- Trade Payables
- 22
- 11
- Total Liabilities
- 73
- 19
- Capital Work in Progress
- 0
- 0
- 14
- 0
- Cash & Bank
- 3
- 37
- Total Assets
- 73
- Total Debt
- 18
- Net Working Capital
- 11
- Contingent Liabilities
- 8
- Book Value per Share
- 24.73
- Face Value
- 10.00
- Total Debt
- 18
- Net Working Capital
- 11
- Contingent Liabilities
- 8
- Book Value per Share
- 24.73
- Face Value
- 10.00
Mar 2018
- Equity Capital
- 12
- 63
- 14
- Trade Payables
- 22
- 7
- Total Liabilities
- 118
- 25
- Capital Work in Progress
- 0
- 0
- 14
- 0
- Cash & Bank
- 23
- 55
- Total Assets
- 118
- Total Debt
- 14
- Net Working Capital
- 50
- Contingent Liabilities
- 4
- Book Value per Share
- 63.68
- Face Value
- 10.00
- Total Debt
- 14
- Net Working Capital
- 50
- Contingent Liabilities
- 4
- Book Value per Share
- 63.68
- Face Value
- 10.00
Mar 2019
- Equity Capital
- 12
- 75
- 12
- Trade Payables
- 31
- 8
- Total Liabilities
- 137
- 24
- Capital Work in Progress
- 15
- 0
- 15
- 0
- Cash & Bank
- 9
- 74
- Total Assets
- 137
- Total Debt
- 12
- Net Working Capital
- 48
- Contingent Liabilities
- 5
- Book Value per Share
- 73.69
- Face Value
- 10.00
- Total Debt
- 12
- Net Working Capital
- 48
- Contingent Liabilities
- 5
- Book Value per Share
- 73.69
- Face Value
- 10.00
Mar 2020
- Equity Capital
- 12
- 110
- 8
- Trade Payables
- 32
- 14
- Total Liabilities
- 176
- 34
- Capital Work in Progress
- 40
- 2
- 17
- 0
- Cash & Bank
- 2
- 81
- Total Assets
- 176
- Total Debt
- 11
- Net Working Capital
- 47
- Contingent Liabilities
- 6
- Book Value per Share
- 98.58
- Face Value
- 10.00
- Total Debt
- 11
- Net Working Capital
- 47
- Contingent Liabilities
- 6
- Book Value per Share
- 98.58
- Face Value
- 10.00
Mar 2021
- Equity Capital
- 12
- 122
- 12
- Trade Payables
- 30
- 16
- Total Liabilities
- 192
- 90
- Capital Work in Progress
- 0
- 2
- 5
- 0
- Cash & Bank
- 3
- 92
- Total Assets
- 192
- Total Debt
- 19
- Net Working Capital
- 42
- Contingent Liabilities
- 5
- Book Value per Share
- 104.52
- Face Value
- 10.00
- Total Debt
- 19
- Net Working Capital
- 42
- Contingent Liabilities
- 5
- Book Value per Share
- 104.52
- Face Value
- 10.00
Mar 2022
- Equity Capital
- 12
- 136
- 21
- Trade Payables
- 42
- 15
- Total Liabilities
- 225
- 92
- Capital Work in Progress
- 0
- 2
- 27
- 0
- Cash & Bank
- 4
- 100
- Total Assets
- 225
- Total Debt
- 26
- Net Working Capital
- 50
- Contingent Liabilities
- 6
- Book Value per Share
- 114.84
- Face Value
- 10.00
- Total Debt
- 26
- Net Working Capital
- 50
- Contingent Liabilities
- 6
- Book Value per Share
- 114.84
- Face Value
- 10.00
Mar 2023
- Equity Capital
- 13
- 180
- 25
- Trade Payables
- 46
- 12
- Total Liabilities
- 275
- 92
- Capital Work in Progress
- 0
- 4
- 45
- 0
- Cash & Bank
- 20
- 113
- Total Assets
- 275
- Total Debt
- 26
- Net Working Capital
- 78
- Contingent Liabilities
- 0
- Book Value per Share
- 146.79
- Face Value
- 10.00
- Total Debt
- 26
- Net Working Capital
- 78
- Contingent Liabilities
- 0
- Book Value per Share
- 146.79
- Face Value
- 10.00
Mar 2024
- Equity Capital
- 13
- 196
- 29
- Trade Payables
- 38
- 16
- Total Liabilities
- 292
- 91
- Capital Work in Progress
- 0
- 8
- 59
- 48
- Cash & Bank
- 15
- 71
- Total Assets
- 292
- Total Debt
- 30
- Net Working Capital
- 70
- Contingent Liabilities
- 0
- Book Value per Share
- 159.34
- Face Value
- 10.00
- Total Debt
- 30
- Net Working Capital
- 70
- Contingent Liabilities
- 0
- Book Value per Share
- 159.34
- Face Value
- 10.00
Mar 2025
- Equity Capital
- 13
- 205
- 26
- Trade Payables
- 41
- 5
- Total Liabilities
- 290
- 86
- Capital Work in Progress
- 0
- 8
- 62
- 59
- Cash & Bank
- 4
- 72
- Total Assets
- 290
- Total Debt
- 27
- Net Working Capital
- 81
- Contingent Liabilities
- 0
- Book Value per Share
- 165.97
- Face Value
- 10.00
- Total Debt
- 27
- Net Working Capital
- 81
- Contingent Liabilities
- 0
- Book Value per Share
- 165.97
- Face Value
- 10.00
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| 6 | 4 | -5 | 4 | 12 | 13 | 5 | -3 | -0 | -3 | |
| Cash from Investing | -1 | -2 | -8 | -15 | -39 | -18 | -8 | -8 | -9 | -2 |
| Cash from Financing | -5 | -1 | 33 | -4 | 21 | 6 | 4 | 28 | 3 | -7 |
| 0 | 0 | 20 | -14 | -6 | 1 | 1 | 17 | -6 | -11 | |
| Free Cash Flow | 5 | 1 | -13 | -11 | -25 | -4 | -4 | -9 | -6 | -5 |
| OCF / Net Profit | 12.90 | 0.70 | -0.54 | 0.36 | 0.96 | 1.04 | 0.32 | -0.23 | -0.02 | -0.28 |
| Cumulative 5-Year FCF | 0 | 0 | 0 | 0 | -43 | -53 | -58 | -54 | -49 | -28 |
| OCF / Net Profit | 12.90 | 0.70 | -0.54 | 0.36 | 0.96 | 1.04 | 0.32 | -0.23 | -0.02 | -0.28 |
| Cumulative 5-Year FCF | 0 | 0 | 0 | 0 | -43 | -53 | -58 | -54 | -49 | -28 |
Mar 2016
- 6
- Cash from Investing
- -1
- Cash from Financing
- -5
- 0
- Free Cash Flow
- 5
- OCF / Net Profit
- 12.90
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 12.90
- Cumulative 5-Year FCF
- 0
Mar 2017
- 4
- Cash from Investing
- -2
- Cash from Financing
- -1
- 0
- Free Cash Flow
- 1
- OCF / Net Profit
- 0.70
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 0.70
- Cumulative 5-Year FCF
- 0
Mar 2018
- -5
- Cash from Investing
- -8
- Cash from Financing
- 33
- 20
- Free Cash Flow
- -13
- OCF / Net Profit
- -0.54
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- -0.54
- Cumulative 5-Year FCF
- 0
Mar 2019
- 4
- Cash from Investing
- -15
- Cash from Financing
- -4
- -14
- Free Cash Flow
- -11
- OCF / Net Profit
- 0.36
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 0.36
- Cumulative 5-Year FCF
- 0
Mar 2020
- 12
- Cash from Investing
- -39
- Cash from Financing
- 21
- -6
- Free Cash Flow
- -25
- OCF / Net Profit
- 0.96
- Cumulative 5-Year FCF
- -43
- OCF / Net Profit
- 0.96
- Cumulative 5-Year FCF
- -43
Mar 2021
- 13
- Cash from Investing
- -18
- Cash from Financing
- 6
- 1
- Free Cash Flow
- -4
- OCF / Net Profit
- 1.04
- Cumulative 5-Year FCF
- -53
- OCF / Net Profit
- 1.04
- Cumulative 5-Year FCF
- -53
Mar 2022
- 5
- Cash from Investing
- -8
- Cash from Financing
- 4
- 1
- Free Cash Flow
- -4
- OCF / Net Profit
- 0.32
- Cumulative 5-Year FCF
- -58
- OCF / Net Profit
- 0.32
- Cumulative 5-Year FCF
- -58
Mar 2023
- -3
- Cash from Investing
- -8
- Cash from Financing
- 28
- 17
- Free Cash Flow
- -9
- OCF / Net Profit
- -0.23
- Cumulative 5-Year FCF
- -54
- OCF / Net Profit
- -0.23
- Cumulative 5-Year FCF
- -54
Mar 2024
- -0
- Cash from Investing
- -9
- Cash from Financing
- 3
- -6
- Free Cash Flow
- -6
- OCF / Net Profit
- -0.02
- Cumulative 5-Year FCF
- -49
- OCF / Net Profit
- -0.02
- Cumulative 5-Year FCF
- -49
Mar 2025
- -3
- Cash from Investing
- -2
- Cash from Financing
- -7
- -11
- Free Cash Flow
- -5
- OCF / Net Profit
- -0.28
- Cumulative 5-Year FCF
- -28
- OCF / Net Profit
- -0.28
- Cumulative 5-Year FCF
- -28
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| PER SHARE | - | - | - | - | - | - | - | - | - | - |
| EPS (₹) | 0.48 | 4.91 | 8.64 | 10.28 | 10.03 | 10.22 | 12.20 | 11.86 | 10.46 | 7.43 |
| Book Value (₹) | 17.92 | 24.73 | 63.68 | 73.69 | 98.58 | 104.52 | 114.84 | 146.79 | 159.34 | 165.97 |
| Dividend per Share (₹) | 0.00 | 0.00 | 1.00 | 1.00 | 0.50 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Cash EPS (₹) | 2.38 | 6.73 | 10.40 | 12.17 | 12.08 | 12.28 | 16.93 | 16.88 | 15.97 | 12.91 |
| PROFITABILITY | - | - | - | - | - | - | - | - | - | - |
| Operating Margin % | 9.25% | 14.42% | 16.73% | 17.23% | 17.07% | 18.87% | 22.36% | 19.64% | 15.80% | 11.29% |
| Net Margin % | 0.71% | 6.26% | 9.06% | 9.81% | 10.45% | 11.34% | 12.91% | 10.88% | 7.71% | 6.24% |
| ROE % | 2.76% | 23.50% | 20.12% | 14.96% | 11.86% | 10.06% | 11.12% | 9.20% | 6.85% | 4.57% |
| ROCE % | 11.36% | 24.10% | 24.91% | 20.22% | 15.26% | 13.12% | 12.82% | 10.95% | 10.13% | 6.96% |
| 0.75% | 7.74% | 10.59% | 9.46% | 7.83% | 6.77% | 7.14% | 6.00% | 4.69% | 3.25% | |
| EFFICIENCY | - | - | - | - | - | - | - | - | - | - |
| Debtor Days | 115 | 92 | 105 | 122 | 136 | 155 | 175 | 161 | 115 | 129 |
| Inventory Days | 67 | 55 | 46 | 44 | 50 | 37 | 51 | 95 | 111 | 146 |
| Payable Days | 284 | 200 | 164 | 138 | 191 | 237 | 299 | 302 | 212 | 226 |
| -102 | -52 | -13 | 28 | -5 | -45 | -73 | -46 | 14 | 50 | |
| FINANCIAL HEALTH | - | - | - | - | - | - | - | - | - | - |
| Debt to Equity (x) | 1.14x | 0.68x | 0.19x | 0.14x | 0.10x | 0.15x | 0.18x | 0.14x | 0.15x | 0.13x |
| Interest Coverage (x) | 1.20x | 2.76x | 6.13x | 13.68x | 18.83x | 12.08x | 10.33x | 6.11x | 3.99x | 4.55x |
| 1.09x | 1.25x | 2.21x | 1.98x | 1.93x | 1.84x | 1.70x | 1.96x | 1.85x | 2.12x | |
| GROWTH | - | - | - | - | - | - | - | - | - | - |
| Revenue Growth % | -13.52% | 22.56% | 35.23% | 9.95% | -4.29% | -6.13% | 4.81% | 19.44% | 25.02% | -12.14% |
| Operating Profit Growth % | 1.43% | 90.90% | 57.01% | 13.12% | -5.14% | 3.74% | 24.22% | 4.89% | 9.11% | -21.01% |
| Net Profit Growth % | 9.14% | 973.02% | 95.98% | 18.92% | 1.94% | 1.86% | 19.38% | 0.64% | -11.36% | -28.96% |
| 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -11.80% | -28.96% | |
| VALUATION | - | - | - | - | - | - | - | - | - | - |
| P/E (x) | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 36.63x | 64.83x |
| P/B (x) | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 2.40x | 2.90x |
| Dividend Yield % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.26% | 0.21% |
| 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 17.00x | 27.27x |
Mar 2016
- EPS (₹)
- 0.48
- Book Value (₹)
- 17.92
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 2.38
- Operating Margin %
- 9.25%
- Net Margin %
- 0.71%
- ROE %
- 2.76%
- ROCE %
- 11.36%
- 0.75%
- Debtor Days
- 115
- Inventory Days
- 67
- Payable Days
- 284
- -102
- Debt to Equity (x)
- 1.14x
- Interest Coverage (x)
- 1.20x
- 1.09x
- Revenue Growth %
- -13.52%
- Operating Profit Growth %
- 1.43%
- Net Profit Growth %
- 9.14%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2017
- EPS (₹)
- 4.91
- Book Value (₹)
- 24.73
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 6.73
- Operating Margin %
- 14.42%
- Net Margin %
- 6.26%
- ROE %
- 23.50%
- ROCE %
- 24.10%
- 7.74%
- Debtor Days
- 92
- Inventory Days
- 55
- Payable Days
- 200
- -52
- Debt to Equity (x)
- 0.68x
- Interest Coverage (x)
- 2.76x
- 1.25x
- Revenue Growth %
- 22.56%
- Operating Profit Growth %
- 90.90%
- Net Profit Growth %
- 973.02%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2018
- EPS (₹)
- 8.64
- Book Value (₹)
- 63.68
- Dividend per Share (₹)
- 1.00
- Cash EPS (₹)
- 10.40
- Operating Margin %
- 16.73%
- Net Margin %
- 9.06%
- ROE %
- 20.12%
- ROCE %
- 24.91%
- 10.59%
- Debtor Days
- 105
- Inventory Days
- 46
- Payable Days
- 164
- -13
- Debt to Equity (x)
- 0.19x
- Interest Coverage (x)
- 6.13x
- 2.21x
- Revenue Growth %
- 35.23%
- Operating Profit Growth %
- 57.01%
- Net Profit Growth %
- 95.98%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2019
- EPS (₹)
- 10.28
- Book Value (₹)
- 73.69
- Dividend per Share (₹)
- 1.00
- Cash EPS (₹)
- 12.17
- Operating Margin %
- 17.23%
- Net Margin %
- 9.81%
- ROE %
- 14.96%
- ROCE %
- 20.22%
- 9.46%
- Debtor Days
- 122
- Inventory Days
- 44
- Payable Days
- 138
- 28
- Debt to Equity (x)
- 0.14x
- Interest Coverage (x)
- 13.68x
- 1.98x
- Revenue Growth %
- 9.95%
- Operating Profit Growth %
- 13.12%
- Net Profit Growth %
- 18.92%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2020
- EPS (₹)
- 10.03
- Book Value (₹)
- 98.58
- Dividend per Share (₹)
- 0.50
- Cash EPS (₹)
- 12.08
- Operating Margin %
- 17.07%
- Net Margin %
- 10.45%
- ROE %
- 11.86%
- ROCE %
- 15.26%
- 7.83%
- Debtor Days
- 136
- Inventory Days
- 50
- Payable Days
- 191
- -5
- Debt to Equity (x)
- 0.10x
- Interest Coverage (x)
- 18.83x
- 1.93x
- Revenue Growth %
- -4.29%
- Operating Profit Growth %
- -5.14%
- Net Profit Growth %
- 1.94%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2021
- EPS (₹)
- 10.22
- Book Value (₹)
- 104.52
- Dividend per Share (₹)
- 1.00
- Cash EPS (₹)
- 12.28
- Operating Margin %
- 18.87%
- Net Margin %
- 11.34%
- ROE %
- 10.06%
- ROCE %
- 13.12%
- 6.77%
- Debtor Days
- 155
- Inventory Days
- 37
- Payable Days
- 237
- -45
- Debt to Equity (x)
- 0.15x
- Interest Coverage (x)
- 12.08x
- 1.84x
- Revenue Growth %
- -6.13%
- Operating Profit Growth %
- 3.74%
- Net Profit Growth %
- 1.86%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2022
- EPS (₹)
- 12.20
- Book Value (₹)
- 114.84
- Dividend per Share (₹)
- 1.00
- Cash EPS (₹)
- 16.93
- Operating Margin %
- 22.36%
- Net Margin %
- 12.91%
- ROE %
- 11.12%
- ROCE %
- 12.82%
- 7.14%
- Debtor Days
- 175
- Inventory Days
- 51
- Payable Days
- 299
- -73
- Debt to Equity (x)
- 0.18x
- Interest Coverage (x)
- 10.33x
- 1.70x
- Revenue Growth %
- 4.81%
- Operating Profit Growth %
- 24.22%
- Net Profit Growth %
- 19.38%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2023
- EPS (₹)
- 11.86
- Book Value (₹)
- 146.79
- Dividend per Share (₹)
- 1.00
- Cash EPS (₹)
- 16.88
- Operating Margin %
- 19.64%
- Net Margin %
- 10.88%
- ROE %
- 9.20%
- ROCE %
- 10.95%
- 6.00%
- Debtor Days
- 161
- Inventory Days
- 95
- Payable Days
- 302
- -46
- Debt to Equity (x)
- 0.14x
- Interest Coverage (x)
- 6.11x
- 1.96x
- Revenue Growth %
- 19.44%
- Operating Profit Growth %
- 4.89%
- Net Profit Growth %
- 0.64%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2024
- EPS (₹)
- 10.46
- Book Value (₹)
- 159.34
- Dividend per Share (₹)
- 1.00
- Cash EPS (₹)
- 15.97
- Operating Margin %
- 15.80%
- Net Margin %
- 7.71%
- ROE %
- 6.85%
- ROCE %
- 10.13%
- 4.69%
- Debtor Days
- 115
- Inventory Days
- 111
- Payable Days
- 212
- 14
- Debt to Equity (x)
- 0.15x
- Interest Coverage (x)
- 3.99x
- 1.85x
- Revenue Growth %
- 25.02%
- Operating Profit Growth %
- 9.11%
- Net Profit Growth %
- -11.36%
- -11.80%
- P/E (x)
- 36.63x
- P/B (x)
- 2.40x
- Dividend Yield %
- 0.26%
- 17.00x
Mar 2025
- EPS (₹)
- 7.43
- Book Value (₹)
- 165.97
- Dividend per Share (₹)
- 1.00
- Cash EPS (₹)
- 12.91
- Operating Margin %
- 11.29%
- Net Margin %
- 6.24%
- ROE %
- 4.57%
- ROCE %
- 6.96%
- 3.25%
- Debtor Days
- 129
- Inventory Days
- 146
- Payable Days
- 226
- 50
- Debt to Equity (x)
- 0.13x
- Interest Coverage (x)
- 4.55x
- 2.12x
- Revenue Growth %
- -12.14%
- Operating Profit Growth %
- -21.01%
- Net Profit Growth %
- -28.96%
- -28.96%
- P/E (x)
- 64.83x
- P/B (x)
- 2.90x
- Dividend Yield %
- 0.21%
- 27.27x
Documents
Announcements
- Updates
2026-08-18 - Medicamen Biotech Limited has informed the Exchange regarding 'Intimation of Book Closure and Record Date in accordance with Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ( Listing Regulations ) '.
- Copy of Newspaper Publication
2026-08-17 - Medicamen Biotech Limited has informed the Exchange about Copy of Newspaper Publication
Annual Reports
Credit Ratings
Nothing filed yet.